find a clinical trial
If you have any questions or are interested in participating in one of our Clinical Trials, please take note of the associated protocol number and contact our team at 201-518-3587, or email us.
60
Clinical Trials
Lymphoma
Phase I
Accepting Patients
nct/study# NCT02732275 / DS3201-A-J101
A Phase 1 Multiple Ascending Dose Study Of DS-3201b In Subjects With Lymphomas
Learn More
Lymphoma
Phase I
Accepting Patients
nct/study# NCT02616965 / HM-085
A Phase I Trial Assessing The Feasibility Of Romidepsin Combined With Brentuximab Vedotin For Patients With Requiring Systemic Therapy For Cutaneous T-Cell Lymphoma
Learn More
Lymphoma
Phase I/II
Accepting Patients
nct/study# NCT03625037 / GCT3013-01
A Phase 1/2, Open-Label, Dose-Escalation Trial Of GEN3013 In Patients With Relapsed, Progressive Or Refractory B-Cell Lymphoma
Learn More
Lymphoma
NA
Accepting Patients
nct/study# NA / 2020-0081
Outcomes Of Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Patients: Real World Experience In Lymphoma Patients
Learn More
Lymphoma
NA
Accepting Patients
nct/study# NA / 2021-0345
Outcomes And Prognostic Factors Of Patients Diagnosed With High-Grade B-Cell Lymphoma, Not Otherwise Specified: A Multi-Institutional Retrospective Study
Learn More
Lymphoma
Phase I/II
Accepting Patients
nct/study# NCT03331198 / 017004
An Open-Label, Phase 1/2 Study Of JCAR017 In Subjects With Relapsed Or Refractory Chronic Lymphocytic Leukemia Or Small Lymphocytic Lymphoma (017004)
Learn Morewe are here for you
For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.